Emerging pathogens

scientific article

Emerging pathogens is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1080/MMY.38.S1.225.236
P698PubMed publication ID11204149

P50authorPierre Ambroise-ThomasQ34020262
Josepa GenéQ36590494
Josep Guarro ArtigasQ36591058
Delphine AldebertQ62757319
P2093author name stringD A Stevens
K V Clemons
D C Coleman
D J Sullivan
J Pontón
J Cano
R Rüchel
A J Carrillo-Muñoz
R Grillot
C Pinel
P921main subjectemerging pathogenQ108429945
P304page(s)225-236
P577publication date2000-01-01
P1433published inMedical MycologyQ6806389
P1476titleEmerging pathogens.
P478volume38 Suppl 1

Reverse relations

cites work (P2860)
Q36246196Activity of posaconazole in the treatment of central nervous system fungal infections
Q34459194Benzothieno[3,2-b]quinolinium and 3-(phenylthio)quinolinium compounds: Synthesis and evaluation against opportunistic fungal pathogens.
Q28547230Characterization of Cell Wall Proteins in Saccharomyces cerevisiae Clinical Isolates Elucidates Hsp150p in Virulence
Q36011378Combination treatment of invasive fungal infections
Q35224754Comparative genomic analysis reveals a critical role of de novo nucleotide biosynthesis for Saccharomyces cerevisiae virulence
Q44630736Comparative virulence of Scedosporium species in animal models
Q43011375Comparison of API20C with molecular identification of Candida spp isolated from bloodstream infections
Q39051666Detection of Candida dubliniensis in Venezuela
Q36933405Development and validation of a quantitative PCR assay for diagnosis of scedosporiosis.
Q36026130Diagnosis of fusariosis in urine cytology
Q44010897Differences in activation of MAP kinases and variability in the polyglutamine tract of Slt2 in clinical and non-clinical isolates of Saccharomyces cerevisiae
Q34619767Disseminated Fusarium infection originating from paronychia in a neutropenic patient: a case report and review of the literature
Q36277042Enrichment of multilocus sequence typing clade 1 with oral Candida albicans isolates in patients with untreated periodontitis
Q42943910Epidemiology of fungaemia in a paediatric hospital of high complexity
Q35073427Evaluation of the new chromogenic medium Candida ID 2 for isolation and identification of Candida albicans and other medically important Candida species
Q36047788Fungal Cell Wall Septation and Cytokinesis Are Inhibited by Bleomycins
Q40634702Fusarium oxysporum as a multihost model for the genetic dissection of fungal virulence in plants and mammals
Q35914298Genome sequencing and comparative analysis of Saccharomyces cerevisiae strain YJM789.
Q44489725Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cerevisiae
Q35599856Glucocorticoids and invasive fungal infections
Q44552191Glycosphingolipids of the model fungus Aspergillus nidulans: characterization of GIPCs with oligo-alpha-mannose-type glycans
Q40644584HIV-1 and its transmembrane protein gp41 bind to different Candida species modulating adhesion
Q42876579In Vitroactivity of conventional antifungal agents againstScedosporium apiospermumisolates recovered from clinical and environmental samples in Nigeria
Q37734590In vitro activity of anidulafungin against selected clinically important mold isolates
Q41355300In vitro inhibitory activities of magnolol against Candida spp.
Q35622021Infections caused by Fusarium species
Q43705836Issues in identifying germ tube positive yeasts by conventional methods.
Q26746939Marine Sponges as a Drug Treasure
Q37762556Mechanisms of antifungal drug resistance in Candida dubliniensis
Q36452663Multilocus sequence typing reveals that the population structure of Candida dubliniensis is significantly less divergent than that of Candida albicans
Q44458603Murine model of disseminated fusariosis: evaluation of the fungal burden by traditional CFU and quantitative PCR.
Q35116244Newer antifungal therapy for emerging fungal pathogens
Q34041713Novel 5-flucytosine-resistant clade of Candida dubliniensis from Saudi Arabia and Egypt identified by Cd25 fingerprinting
Q43215984Occurrence of yeasts in psittacines droppings from captive birds in Italy
Q28306629Polarisome meets spitzenkörper: microscopy, genetics, and genomics converge
Q43883282Prevalence of Candida dubliniensis among cancer patients in Kuwait: a 5-year retrospective study
Q44045225Prevalence of fungal infections detected from biopsies and autopsies in the past 11 years at the University Hospital Joan XXIII in Tarragona, Spain
Q34455991Prospective evaluation of the new chromogenic medium Candida ID, in comparison with Candiselect, for isolation of molds and isolation and presumptive identification of yeast species
Q39751370Racial Distribution of Candida dubliniensis Colonization among South Africans
Q42708818Reduced azole susceptibility in genotype 3 Candida dubliniensis isolates associated with increased CdCDR1 and CdCDR2 expression
Q42582639Role of nitrogen and carbon transport, regulation, and metabolism genes for Saccharomyces cerevisiae survival in vivo
Q42361178Saccharomyces cerevisiae show low levels of traversal across human endothelial barrier in vitro.
Q35194598Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide
Q35622016Scedosporium species infections and treatments
Q31035863Synthetic combinatorial libraries as an alternative strategy for the development of novel treatments for infectious diseases
Q35561978The 100-genomes strains, an S. cerevisiae resource that illuminates its natural phenotypic and genotypic variation and emergence as an opportunistic pathogen
Q52860259The use of Niger seed agar to screen for Candida dubliniensis in the clinical microbiology laboratory
Q41787399Universal in vitro antifungal resistance of genetic clades of the Fusarium solani species complex
Q34764156Use of CHROMagar Candida for the presumptive identification of Candida species directly from clinical specimens in resource-limited settings
Q35825582Voriconazole, a novel wide‐spectrum triazole: oral pharmacokinetics and safety
Q81533852[In vitro activity of the echinocandins. How should it be evaluated?]

Search more.